Member Info for Poidster

@trouble, you ok hun ? You seem grumpier than normal tonight

@DRB, I understand the passage of text you have posted re hiberplex but I'm not sure it's of any relevance to Novacyt, this seems to be referring to treatment protocols, not diagnostics. I probably need a little more context tbh

Hill, good points, it was a question from my part and since I bought in ive always had a long term vision so happy (ish) to ride this out but just had a thought that my strategy may be scuppered. With the responses that fear has been put to bed so I appreciate the feedback from everyone.
BTW I was never insinuating that the BOD were complicit in any of this, they are kind a victim of their own success too.
On a brighter note, think novacyt very well placed for this sounds very similar to the disbanded Phase 2, does it not.
If I were in charge of procurement for this project Novacyts name would be the top of the list, its exactly what they were designed for, now even enhanced with co prep, means training and set up minimal.
I reckon if I was a project manger for these labs, I could have them up and running in less than 6 weeks from the start of project

Co prep and q32 machines in a community diagnostic hub would be a match made in heaven, if a few of these workstations were installed per hub, it would give massive extra capacity in the community in a very short space of time. I hope novacyt are in the offing for this, they are the best of type in this scenario, with the fastest turn around time and highest capacity than any other player in this space

I did Chris thanks, I seem to get quite a few of my threads and comments deleted for some reason don't think anything I post is overtly controversial, just trying to make sense of my investment

*me troubled

Kaeren, not sure i understand your fully loaded comment tbh, but the observation you made earlier this week is leaving troubled and I can't resolve it.
WHO exactly interviewed DA, nothing I can think of makes any sense in this situation. If it was the BOD which members, it must have included GM, how could it not and yet DA wasn't introduced, no one seems to know anything about him, who is pulling the strings here. None of this makes any sense. If GM was the encumbent CEO in charge, surely he would have introduced his successor, given that he should have been pivotal in his appointment.
Answers on a postcard please, I can't fathom this out at all

Oh give over, 1) who cares 2) why are you bothered.

I'm beginning to get more than a little concerned recently, after recent news to me, was that any company wanting to take over, only had to offer over their highest buy in price in the last 12 months.
We all know the value, long term, of this company.
The SP seems ludicrously low on AIM for a company with the fundamentals of Novacyt and the future potential.
So, a question that's just dawned on me, the SP, to me, looks like its being artificially suppressed over the last 10 months.
The removal of GM, who IMO, didn't want to leave, plus other board members too, who seem to have departed without a whimper. The news blackout since the DHSC dispute. The new CEO who hasn't said a word yet, despite being announced a few months ago. The fact that said CEO wasn't on the AGM call, nobody seemed to know anything about him.
Are Novacyt being taken over on the cheap, by stealth.
I always thought, I've done my research, I know this field, the R&D is the best in the world. Sit tight, ride out the storm and hold for the future, happy days.
I'm now left wondering if there are other games afoot.
These are just my musings and trying to scratch in places I don't really want to tbh but this has been bugging me for a few days now.
I'm open to any and all opinions, just thought I'd put it out there.
I'm going to dig out my KY, because I've got a horrible feeling I'm about to be royally shafted.
Alternative views are both expected and indeed welcome

Do you know that Randox at the beginning of the pandemic were very aggressively bidding and being put forward as a prime lab testing supplier. 1000s of tests were sent to them, they are based in Ireland, they couldn't cope, so they were flown to the USA, who pretty much lost or couldn't process the samples. I wonder how much that all cost and it was a total waste of time and huge amounts of money

Should be put on trial let alone suspended

Quoting Confucius, nice, I prefer Rocky Balboas' version tbh

@B2H thats not an unreasonable assumption, versalab can be deployed anywhere and there's absolutely no mandatory requirement for Co Prep, exactly how its being used now.
It requires more skill to use reliably.
By introducing co prep they have made this even easier to use, so its another option that could be bolted on to improve accuracy and efficiency but its not essential.
I can't think of many scenarios whereby versalab would be deployed and used by a single individual, if there's an ebola outbreak in Africa, for example, there would be a whole team deployed to that area, with all the associated PPE etc required, one extra suitcase or crate for co prep wouldn't be an excessive burden.
Novacyt are simply just knocking down barriers that would prevent adoption

@B2H, yes there are now several other platforms that are fully automated, so just load the samples and press go.
This isn't the marketplace novacyt are targeting, they are going down the POC route. The main lab analyser market is crowded with the big boys, thermo Fisher, Roche, Abbott etc.
I think their marketing strategy is a good one. Whats required for covid is a testing platform that can be easily deployed anywhere, can be used by anyone with next to no training and gives high quality results in a very short timescale.
The big analysers are high volume but take about 4 hrs before the first results start coming off, fine for hospital routine screening but no use in an airport for example.
Plus the Q machines can test for a multitude of things, its not just a covid testing platform.
I travelled to Tanzania in 2019, yellow fever is endemic in this area of Africa and proof of vaccination etc was required before being allowed into the country , they were very stringent on checking this too.
So there's no reason why the q machines couldn't be deployed in these countries to help limit the spread of some very nasty diseases

@Steve annnd I thank you. I think its largely me that is responsible for putting forward. I knew I had read it somewhere but I couldn't find it. I even went thru the latest contract I could find on line and still couldn't find it, I don't know if its now been redacted or if I just wasn't paying attention.
I knew I hadn't just made it up so thanks for the clarification

The most salient point about co prep automation is that it takes away the requirement for accurate pipetting on the end users part.
Novacyt have now removed the last barrier to make this a very reliable and efficient point of care testing platform.
With the minute volumes involved, accurate pipetting is an essential skill and tbf its not easy and requires a significant amount of skill and expertise to do it repeatedly, inaccurate pipetting will lead to erroneous results.
Now they have come up with a solution, with a very small footprint that means the q machines can be literally used by anyone with minimal training in any environment and still get good results. They have also said it can be used for other tests on their platform, probably just need to select a different program for different tests.
This truly is now a very sensitive and specific test that can be reliably deployed as a true POC platform. Yet again, Novacyt are well ahead of the curve. Other platforms currently in this space are single test. Novacyts can test multiple tests per run.
I'm again starting to feel optimistic for the future

@Troublesome ROFL, took me a minute to think then, I thought whats he going on about.... Yh Feeling a bit RRRuFFF

@Sir Digby, hes only 54 and is already looking for other positions via LinkedIn, so he's clearly not retiring. The tone of the AGM/EGM was all a bit odd, as was DA none appearance, it doesn't feel like an amicable departure. I thought Kaeren made a good observation earlier that was overlooked, none of the existing BOD seemed to know anything about DA, so who the hell interviewed him for the position ?
In my opinion, which is just that and based on no inside info, changes are afoot. The unexplained 10%+ rise today. something's hsppening

The requirement for a Winterplex type test is going to be the number 1 priority for hospitals this winter, RSV, Flu and Covid all present with pretty much the same symptoms early on, so differentiating between what is or isn't causing the infection is vital this winter.
Think I need to read more about what Co Prep does and doesn't do, think If they are focussing more on the near patient testing market using Promate, which is still quite technical tbh, then I'm barking up the wrong tree

I was quite perplexed by the fact that Novacyt hadn't produced a promate version of winterplex, as it stands, winterplex will have the same push back from busy labs for the same reasons that Exsig did.
Been mulling this over
Just had a thought, the reason they may have not done a winterplex promate type test is to encourage sales of coprep machine.
I don't know the specifics about it but if it automates all the pre prep stages that exsig required, then it removes those barriers,
I suspect the manufacturing process for promate is more expensive than just providing the separate reagents.
Just a thought